Lucid Diagnostics Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 1.55M | $1.79M | 0.00% | Added+14.9% | 2026-03-31 |
| RenTech | quant | 499.7K | $574.61K | 0.00% | Trimmed-39.5% | 2026-03-31 |
| FidelityFMR | fundamental | 120.6K | $138.66K | 0.00% | Added+289.5% | 2026-03-31 |
| TRowePrice | fundamental | 74.4K | $86 | 0.00% | Added+111.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.06 | — | — |
| 2026-05-14 | -0.06 | -0.07 | -10.53% |
| 2026-03-26 | -0.09 | -0.10 | -15.38% |
| 2025-11-12 | -0.09 | -0.10 | -15.38% |
| 2025-08-13 | -0.10 | -0.10 | — |
| 2025-05-14 | -0.11 | -0.16 | -41.18% |
| 2025-03-24 | -0.15 | -0.19 | -29.54% |
| 2024-11-13 | -0.18 | -0.20 | -11.11% |
| 2024-08-12 | -0.18 | -0.20 | -11.11% |
| 2024-05-13 | -0.22 | -0.21 | +5.97% |
| 2024-03-25 | -0.20 | -0.23 | -15.00% |
| 2023-11-13 | -0.22 | -0.22 | +1.49% |
| 2023-08-13 | -0.27 | -0.23 | +15.85% |
| 2023-05-15 | -0.30 | -0.24 | +20.88% |
| 2023-03-14 | -0.32 | -0.30 | +7.28% |
| 2022-11-14 | -0.32 | -0.28 | +13.40% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| LUCD | -5.50% | -28.97% | -5.50% | -25.90% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -8.47% | -24.33% | -2.06% | -38.59% |